ROIV — Roivant Sciences Ltd. stock price, charts and financials

QT57Roivant Sciences Ltd.

Roivant Sciences Ltd. (NASDAQ: ROIV) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
34.59
+1.27+3.81%
ROIVQT57Roivant Sciences Ltd.·NASDAQ
34.59+3.81%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 2026DEF 14ADefinitive proxy statement
Jul 29, 2026ARSAnnual report to shareholders
Jul 29, 2026DEFA14AAdditional proxy soliciting materials
Jul 21, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 20, 20268-KCurrent report
May 20, 202610-KAnnual report
May 20, 2026S-8Registration of employee benefit securities
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)